B C BIOSIMILARS COUNCIL A DIVISION OF AAM Trademark

Trademark Overview


On Friday, March 4, 2022, a trademark application was filed for B C BIOSIMILARS COUNCIL A DIVISION OF AAM with the United States Patent and Trademark Office. The USPTO has given the B C BIOSIMILARS COUNCIL A DIVISION OF AAM trademark a serial number of 97295418. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, February 26, 2024. This trademark is owned by Association for Accessible Medicines. The B C BIOSIMILARS COUNCIL A DIVISION OF AAM trademark is filed in the Advertising, Business and Retail Services category with the following description:

Association services, namely, promoting awareness of biosimilars in the United States with the intent of expanding access to and availability of biological medicines and improving health care; providing information to inform and support public policies that encourage awareness of, access to, and adoption of biosimilars; promoting the interest of biosimilars development and adoption by means of public advocacy
b c biosimilars council a division of aam

General Information


Serial Number97295418
Word MarkB C BIOSIMILARS COUNCIL A DIVISION OF AAM
Filing DateFriday, March 4, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, February 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the letter "B" in the center of a larger letter "C" with three circle designs in different sizes on the right together with the words "BIOSIMILARS COUNCIL" in larger font above "A DIVISION OF AAM" in smaller font.
Section 2(f) Limitation StatementAs to BIOSIMILARS COUNCIL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAssociation services, namely, promoting awareness of biosimilars in the United States with the intent of expanding access to and availability of biological medicines and improving health care; providing information to inform and support public policies that encourage awareness of, access to, and adoption of biosimilars; promoting the interest of biosimilars development and adoption by means of public advocacy

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 9, 2022
Primary Code035
First Use Anywhere DateThursday, February 10, 2022
First Use In Commerce DateThursday, February 10, 2022

Trademark Owner History


Party NameAssociation for Accessible Medicines
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWashington, DC 20001

Trademark Events


Event DateEvent Description
Monday, February 26, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 26, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, November 2, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, November 2, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, August 8, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 8, 2023FINAL REFUSAL E-MAILED
Tuesday, August 8, 2023FINAL REFUSAL WRITTEN
Tuesday, June 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 9, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, March 9, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 27, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 27, 2022NON-FINAL ACTION WRITTEN
Thursday, December 15, 2022ASSIGNED TO EXAMINER
Thursday, March 10, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 8, 2022NEW APPLICATION ENTERED